Haemonetics HAE Hospital — D&A

Similar metrics at other companies

THCHospital Operations — D&A

$174M+0.6%

UHSAcute Care Hospital Services — D&A

$106.62M+10.5%

FSID&A

$509.5K+9.5%

LYBI&D — D&A

$104M+5.1%

MYRGT&D — D&A

$15.92M+11.7%

AEPT&D — D&A

$217M+6.9%

FAQ

What is Haemonetics's hospital — D&A?

Haemonetics (HAE) reported hospital — D&A of $14.3M in Q1 2026.

How has Haemonetics's hospital — D&A changed year-over-year?

Haemonetics's hospital — D&A decreased by 0.1% year-over-year, from $14.31M to $14.3M.

What is the long-term trend for Haemonetics's hospital — D&A?

Over 2 years (2024 to 2026), Haemonetics's hospital — D&A has grown at a 22.5% compound annual growth rate (CAGR), from $38.11M to $57.19M.

What does hospital — D&A mean?

Reflects the non-cash allocation of the cost of tangible and intangible assets over their useful lives within the hospital segment. This metric is essential for understanding the capital intensity of the segment and the ongoing investment required to maintain its operational capacity.